MedPath

A clinical trial to study the effect of two drugs saptaparna bark and chirabilva bark in patients with Kitibha kushta (psoriasis)

Phase 2
Conditions
Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Registration Number
CTRI/2022/10/046834
Lead Sponsor
Dr.Vinoda Y Sidaraddi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects who are willing to be a part of research work.

Subjects with chronicity not more than 2yrs.

Subjects with mild to moderate disease.

Exclusion Criteria

1.subjects with Kitibha kushta having extracutaneous manifestations.

2.subjects with other systematic disorders like DM,HTN,Asthama.

3.pregnant women and lactating mothers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath